Page results
-
UCLH has moved one step closer to carbon net zero emissions with the installation of six new mobile Entonox destructions units across our birthing centre and labour wards.
-
A directory of UK organisations which provide specialist support to anyone affected by cancer or a blood condition
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
-
In his darkest moments, coronavirus patient Ertan Nazim feared he wouldn’t live to celebrate his 44th wedding anniversary.
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
The research team said the placenta acted as a barrier to transmission.
-
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).
-
UCLH is to trial the COVID-19 vaccine developed by University of Oxford in healthy staff volunteers.
-
Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.
-
Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study supported by the NIHR UCLH Biomedical Research Centre and UCLH Charity.
File results
-
-
-
-
-
-
FOI/2023/0568 - Adverse reactions to the Astra Zeneca Covid vaccine
-
FOI/2023/0486 - Mastectomy reconstruction
-
FOI/2023/0603 - Treatment of dermatological conditions
-
FOI/2023/0447 - Excessive exposure to Nitrous Oxide via Entonox from 2018-2023
-
FOI/2023/0497 - List of all laboratories within Pathology